BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 31248522)

  • 1. Discussion.
    J Am Coll Surg; 2019 Jul; 229(1):27-29. PubMed ID: 31248522
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunotherapy for pancreatic cancer: A long and hopeful journey.
    Xu JW; Wang L; Cheng YG; Zhang GY; Hu SY; Zhou B; Zhan HX
    Cancer Lett; 2018 Jul; 425():143-151. PubMed ID: 29605510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biological response modifier--immunotherapeutic approaches in pancreatic cancer.
    Schmiegel W
    Hepatogastroenterology; 1989 Dec; 36(6):456-8. PubMed ID: 2693301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunotherapy in pancreatic cancer: New hope or mission impossible?
    Jiang J; Zhou H; Ni C; Hu X; Mou Y; Huang D; Yang L
    Cancer Lett; 2019 Mar; 445():57-64. PubMed ID: 30641107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunotherapy of pancreatic carcinoma.
    Märten A
    Rev Recent Clin Trials; 2008 May; 3(2):121-5. PubMed ID: 18474022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunotherapeutic Approaches in Pancreatic Adenocarcinoma: Current Status and Future Perspectives.
    Yee NS
    Curr Mol Pharmacol; 2016; 9(3):231-241. PubMed ID: 26177643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human Vaccines & Immunotherapeutics: News.
    Hum Vaccin Immunother; 2017 Mar; 13(3):491-492. PubMed ID: 28300500
    [No Abstract]   [Full Text] [Related]  

  • 8. [Possibilities of immunotherapy of colorectal cancers and pancreatic tumors].
    Klapdor R
    Z Gastroenterol Verh; 1991 Mar; 26():220-7. PubMed ID: 1714155
    [No Abstract]   [Full Text] [Related]  

  • 9. Novel agents for the treatment of pancreatic cancer.
    Brennan GT; Relias V; Saif MW
    JOP; 2014 Mar; 15(2):110-3. PubMed ID: 24618430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Algenpantucel-L immunotherapy in pancreatic adenocarcinoma.
    Coveler AL; Rossi GR; Vahanian NN; Link C; Chiorean EG
    Immunotherapy; 2016 Feb; 8(2):117-25. PubMed ID: 26787078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of immunotherapy for pancreatic cancer.
    Kawakami Y; Okada T; Akada M
    Pancreas; 2004 Apr; 28(3):320-5. PubMed ID: 15084980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Immunologic therapeutic approaches in malignant diseases, especially in pancreatic tumors].
    Kalden JR
    Verh Dtsch Ges Pathol; 1987; 71():266-70. PubMed ID: 3326332
    [No Abstract]   [Full Text] [Related]  

  • 13. The tumor immune microenvironment in gastroenteropancreatic neuroendocrine neoplasms.
    Zhang WH; Wang WQ; Gao HL; Yu XJ; Liu L
    Biochim Biophys Acta Rev Cancer; 2019 Dec; 1872(2):188311. PubMed ID: 31442475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neoantigen identification strategies enable personalized immunotherapy in refractory solid tumors.
    Chen F; Zou Z; Du J; Su S; Shao J; Meng F; Yang J; Xu Q; Ding N; Yang Y; Liu Q; Wang Q; Sun Z; Zhou S; Du S; Wei J; Liu B
    J Clin Invest; 2019 May; 129(5):2056-2070. PubMed ID: 30835255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunological approach in the diagnosis, therapy and prognosis of the exocrine pancreatic cancer.
    Bădulescu F; Bădulescu A; Rogoz S; Mustaţă R
    Roum Arch Microbiol Immunol; 2001; 60(1):5-16. PubMed ID: 11850897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunotherapy of pancreatic cancer.
    Sunami Y; Kleeff J
    Prog Mol Biol Transl Sci; 2019; 164():189-216. PubMed ID: 31383405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A mathematical prognosis model for pancreatic cancer patients receiving immunotherapy.
    Li X; Xu JX
    J Theor Biol; 2016 Oct; 406():42-51. PubMed ID: 27338302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Robo1-specific CAR-NK Immunotherapy Enhances Efficacy of
    Xia N; Haopeng P; Gong JU; Lu J; Chen Z; Zheng Y; Wang Z; Sun YU; Yang Z; Hoffman RM; Liu F
    Anticancer Res; 2019 Nov; 39(11):5919-5925. PubMed ID: 31704816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regional immunotherapy for liver and peritoneal metastases.
    Reha J; Katz SC
    J Surg Oncol; 2017 Jul; 116(1):46-54. PubMed ID: 28543176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunologic approaches to the management of pancreatic cancer.
    Laheru D; Biedrzycki B; Jaffee EM
    Cancer J; 2001; 7(4):324-37. PubMed ID: 11561608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.